门诊不同压力无创正压通气对慢性阻塞性肺疾病稳定期合并Ⅱ型呼吸衰竭肺康复影响研究被引量：23

Effects of long-term different-intensity noninvasive ventilation on pulmony rehabilitation of outpatients with stable chronic obstructive pulmonary disease complicated by type Ⅱ respitatory failure

原文传递

导出

摘要目的探讨长期门诊不同压力无创正压通气对慢性阻塞性肺疾病（慢阻肺）稳定期合并Ⅱ型呼吸衰竭患者肺康复的影响。方法将2011年10月至2014年10月广东药学院附属第一医院呼吸内科118例慢阻肺稳定期合并Ⅱ型呼吸衰竭患者随机分为两组，其中高压通气组58例，设置吸气压力水平（IPAP）为1．76～2．94kPa；低压通气组60例，IPAP为0．98～1．76kPa。两组患者在门诊接受．g44正压通气治疗1年。比较两组患者治疗1年前后的血气分析、肺功能、呼吸困难症状、运动能力、生活质量、急性加重住院次数、平均住院时间、平均住院费用以及生存率等指标变化。结果高压通气组与低压通气组相比，动脉血二氧化碳分压（PaCO2）、氧分压（PaO2）、改良英国医学研究委员会呼吸困难量表（mMRC）评分、圣乔治呼吸问卷评分（SGRQ）、第一秒用力呼吸容积占预计值百分比（FEV1％）、用力肺活量（FVC）均显著改善（P〈0．05）。1年内急性加重住院次数、平均住院时间和平均住院费用均显著下降（P〈0．05）。两组患者6min步行距离（6MWD）、FEV，／FVC差异无统计学意义。两组患者生存率比较差异无统计学意义（91．4％对86．6％，P=0．414）。结论慢阻肺稳定期合并Ⅱ型呼吸衰竭患者门诊长期应用高压力无创正压通气可显著改善患者肺功能、纠正二氧化碳潴留，提高患者生活质量，减少呼吸困难症状、急性加重住院次数和平均住院费用，是一种有效的肺康复手段。 Objective To explore the effects of long-term different-intensity noninvasive ventilation on patients with stable chronic obstructive pulmonary disease（COPD） complicated by type 1I respitatory failure. Methods Totally 118 patients with stable COPD were divided randomly into two groups： high-intensity group （1PAP 1.76-2.94 kPa, n=58） and low-intensity group （IPAP 0.98-1.76 kPa, n=60）. All patients received noninvasive ventilation for at least one year. Gas exchange, pulmonary function, dyspnea, exercise tolerance, health-related quality of life, hospital admissions, hospital stay average hospital cost and survival rate were compared between two groups before and after the treatment. Results Compared with low-intensity group, high-intensity group showed an significant improvement in gas exchange, mMKC, SGKQ, hospital admissions, hospital stay and average hospital cost （P〈0.05）. No significant differences in sixminute walking distance and FEV1/FVC were found between the two groups （P〉0.05）. Survivalwas similar in both groups （91.4% vs 86.6% P=0.414）. Conclusion Long-term high-intensity noninvasive ventilation for patients with stable COPD may exert preferable potential in improving pulmonary function, carbon dioxide retention and health-related quality of life and dyspnea, as well as reducing hospitalisations and average hospital cost, so it is effective in pulmonary rehabilitation.

作者谭杰罗鹏陈宜泰周露茜罗裕文崔莉李兰英陈新

机构地区广东药学院附属第一医院呼吸内科南方医科大学珠江医院呼吸内科呼吸疾病国家重点实验室广州医科大学附属第一医院广州呼吸疾病研究所

出处《中国实用内科杂志》 CAS CSCD 北大核心 2016年第8期671-674,共4页 Chinese Journal of Practical Internal Medicine

基金广东省科技计划项目(2013B022000072 2014A020215033) 广州市科技计划项目(201507020033) 广州医科大学科研基金(2014c22)

关键词慢性阻塞性肺疾病 Ⅱ型呼吸衰竭无创正压通气肺康复 chronic obstructive pulmonary disease type Ⅱ respiratory failurei noninvasive ventilationl pulmonary rehabilitation

分类号 R544.1 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献11

1Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (updated 2015)[EB/OL].(2015-08-18)[2016-01-25]. http://www.goldcopd. it / gruppi_lavoro/goldwr2005dean.p dr.
2Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64.
3Mcevoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial[J]. Thorax, 2009, 64(7): 561-566.
4Dreher M, Storre JH, Schmoor C, et al. High-intensity versus low- intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial[J]. Thorax, 2010, 65(4): 303-308.
5Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease[J]. Respiration, 2012, 84(1): 17-26.
6孙丽娜,陈亚红.慢性阻塞性肺疾病新病情评估方法的分布及预后价值[J].中国实用内科杂志,2014,34(8):808-810. 被引量：13
7孙永昌.识别慢性阻塞性肺疾病急性加重感染因素对个体化治疗指导作用[J].中国实用内科杂志,2015,35(5):389-391. 被引量：4
8Struik FM, Lacasse Y, Goldstein RS, et al. Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis [j]. gespir Med, 2014, 108(2): 329-337.
9Kohnlein T, Windisch W, Kohler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial[J]. Lancet Respir Med, 2014, 2(9): 698-705.
10Windisch W, Kosti S, Dreher M, et al. Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of PaCO2[J]. Chest, 2005,128(2): 657-662.

二级参考文献23

1Vestho J, Hurd SS, Agusti AG, et al. Global initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, manage- ment,and prevention of Chronic obstructive pulmonary disease re- vised 2011 [J]. Am J Respir Crit Care Med,2013 ,187 :347 -365.
2Johannessen A, Nilsen RM, Storebo M, et al. Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitaliza- tion[J]. Am J Respir Crit Care Med,2013,188(1) :51 -59.
3Agusti A, Edwards L, Celli B, et al. Characteristics, stability and out- comes of the GOLD 2011 COPD groups in the ECLIPSE cohort[J]. Eur Respir J,201S ,42(3 ) :636 -646.
4Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD clas- sification[J]. Am J Respir Crit Care Med,2012,186:975 -981.
5Soriano JB,Alfajame I,Almagro Pet al. Distribution and pro:osticvalidity of the new GOLD grading classification [ J ]. Chest, 2013, 143 ( 3 ) :694 - 702.
6Han MK,Mullerova H,Curran-Everett D,et al. GOLD 2011 disease severity classification in COPDGene:a prospective cohort study [ J ]. Lancet Respir Med ,2013,1 ( 1 ) :43 - 50.
7Jones PW, Adamek L, Nadeau G, et al. Comparisons of health status scores with MRC grades in a primary care COPD population:Impli- cations for the new GOLD 2011 classification [ J ]. Eur Respir J, 2013.42(3) :647 -654.
8McAllister DA, Maclay JD, Mills NL, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD [ J ]. Eur Respir J,2012,39 : 1097 - 1103.
9Brekke PH, Omland T, Smith P, et al. Underdiagnosis of myocardial infarction in COPD-Cardiac Infarction Injury Score ( CIIS ) in pa- tients hospitalised for COPD exacerbation [ J ]. Respir Med, 2008, 102 : 1243 - 1247.
10Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and oth- er co-morbidities in patients with chronic obstructive pulmonary disease : a Danish nationwide study of 7.4 million individuals [ J ]. Eur Heart J ,2011,32:2365 - 2375.